Cholera Cases and Deaths Rising Sharply in Africa Amid Infrastructure Challenges
Cholera cases and deaths in Africa have increased significantly in 2024, with the WHO reporting a 5% rise in cases and 50% rise in deaths compared to 2023, totaling over 6,000 deaths. The disease spreads through contaminated water sources and is exacerbated by conflict, climate change, and poor water and sanitation infrastructure in affected regions. Cholera is preventable and treatable, making these deaths particularly concerning given the disease's long history and the availability of interventions.
According to the World Health Organization, cholera cases and deaths in Africa have risen sharply in 2024 compared to 2023, with reported cases up 5% and deaths up 50%, resulting in over 6,000 deaths. The disease spreads through contaminated water, allowing entire communities to become infected simultaneously from a single contaminated source. Contributing factors include ongoing conflicts in Sudan and the Democratic Republic of the Congo, earthquakes, natural disasters, and climate change, all of which have damaged water infrastructure and forced populations to rely on contaminated water sources. Cholera is caused by a bacterium that triggers severe, rapid dehydration and can be fatal within hours if untreated, though it is both preventable and treatable with proper medical care and access to clean water. The current outbreak represents part of the seventh cholera pandemic, which began in Southern Asia 65 years ago and has since spread globally, with the WHO estimating 1.3 to 4.0 million cases and 21,000 to 143,000 deaths annually worldwide.
What's missing
The article does not specify which African countries or regions are currently most affected by the 2024 cholera outbreak, nor does it provide information on vaccination coverage rates or the availability of oral rehydration therapy and other treatment resources in affected areas.
What different sources said
- Daily WireRight
The Pandemic Nobody’s Talking About — And It’s Not Ebola
Related
Sydney Psychiatrist Retains Medical License After Sexual Assault Conviction
Gopi Ilawala, a Sydney psychiatrist convicted of sexually assaulting an intoxicated colleague in 2022, has been allowed to continue practicing medicine despite the state health regulator seeking to have his registration cancelled. The New South Wales Civil and Administrative Tribunal reprimanded him and imposed conditions rather than striking him off, citing his remorse, lack of prior convictions, and support from two senior psychiatrists. The decision raises questions about professional accountability and public protection in medical regulation.
Australia's TGA to crack down on illegal peptides; government allocates $100m for arthritis research
Australia's Therapeutic Goods Administration has announced a crackdown on illegal peptides due to a surge in imports and online advertising, designating them a priority focus area. The federal government has simultaneously committed $100 million to medical research into arthritis prevention, diagnosis, and treatment. These developments reflect growing regulatory concerns about unregulated drugs and increased investment in chronic disease research.
GLP-1 Drugs Like Ozempic May Help ADHD Symptoms, According to Patient Reports and Clinical Observations
Social media users and some patients are reporting that GLP-1 receptor agonist drugs like Ozempic appear to improve ADHD symptoms, including increased focus, reduced procrastination, and better impulse control. GLP-1s were originally developed to treat Type 2 diabetes but are being studied for various other conditions. While anecdotal reports are growing, no formal clinical trials are currently testing these drugs specifically for ADHD, and the mechanism behind any potential benefit remains unclear.